Clinical Trials Directory

Trials / Completed

CompletedNCT05026437

CASUS vs. APACHE II in Predicting Mortality After Coronary Artery Bypass Grafting

The Value of CASUS vs. APACHE II in Predicting Mortality Among Patients Undergoing Coronary Artery Bypass Grafting

Status
Completed
Phase
Study type
Observational
Enrollment
204 (actual)
Sponsor
Antalya Training and Research Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study seeks to determine the value of CASUS in predicting mortality as compared with APACHE II scoring system among patients undergoing coronary artery bypass grafting.

Detailed description

Patients undergoing coronary artery bypass grafting will prospectively studied after the admission to the cardiac intensive care unit. Data on the preoperative condition, intraoperative parameters, and postoperative course will collected. CASUS and APACHE II scores will calculated on the first postoperative day. Clinical outcomes are defined as 7-day mortality, 30-day mortality and morbidity. Morbidity includes variables such as length of stay in the cardiac surgical intensive care unit and in the hospital.

Conditions

Interventions

TypeNameDescription
OTHERCardiac surgery score and APACHE II scoringCardiac surgery score and APACHE II will calculated on the first postoperative day.

Timeline

Start date
2019-01-02
Primary completion
2019-03-10
Completion
2019-04-10
First posted
2021-08-30
Last updated
2021-08-30

Locations

2 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05026437. Inclusion in this directory is not an endorsement.